ResMed Global revenue — Net revenue by segment increased by 0.6% to $1.43B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $1.29B to $1.43B. Over 3 years (FY 2021 to FY 2024), Global revenue — Net revenue by segment shows an upward trend with a 13.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration, strong product demand, or effective pricing strategies, while a decrease may signal competitive pressure, supply chain constraints, or a contraction in the addressable market.
This metric represents the total net sales generated by the company's global operations after accounting for returns, al...
Comparable to total net revenue reported by other global medical device manufacturers, though it should be benchmarked against peers with similar geographic exposure and product portfolios.
rmd_segment_global_revenue_net_revenue_by_segment| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $876.10M | $904.02M | $894.87M | $864.50M | $914.74M | $950.29M | $1.03B | $1.12B | $1.12B | $1.10B | $1.16B | $1.20B | $1.22B | $1.22B | $1.28B | $1.29B | $1.34B | $1.42B | $1.43B |
| QoQ Change | — | +3.2% | -1.0% | -3.4% | +5.8% | +3.9% | +8.8% | +8.0% | +0.5% | -1.8% | +5.5% | +2.9% | +2.2% | +0.1% | +4.7% | +0.8% | +3.4% | +6.5% | +0.6% |
| YoY Change | — | — | — | — | +4.4% | +5.1% | +15.5% | +29.2% | +22.7% | +16.0% | +12.5% | +7.2% | +9.0% | +11.1% | +10.3% | +7.9% | +9.1% | +11.0% | +10.8% |